Curran MA - Search Results

1

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Curran MA, Montalvo W, Yagita H, Allison JP. Curran MA, et al. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4275-80. doi: 10.1073/pnas.0915174107. Epub 2010 Feb 16. Proc Natl Acad Sci U S A. 2010. PMID: 20160101 Free PMC article.

2

Immune rejection of mouse tumors expressing mutated self.

Duan F, Lin Y, Liu C, Engelhorn ME, Cohen AD, Curran M, Sakaguchi S, Merghoub T, Terzulli S, Wolchok JD, Houghton AN. Duan F, et al. Cancer Res. 2009 Apr 15;69(8):3545-53. doi: 10.1158/0008-5472.CAN-08-2779. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351857 Free PMC article.

3

Preclinical Data Supporting Antitumor Activity of PD-1 Blockade.

Curran MA. Curran MA. Cancer J. 2018 Jan/Feb;24(1):2-6. doi: 10.1097/PPO.0000000000000298. Cancer J. 2018. PMID: 29360721 Review.

4

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.

Singh M, Vianden C, Cantwell MJ, Dai Z, Xiao Z, Sharma M, Khong H, Jaiswal AR, Faak F, Hailemichael Y, Janssen LME, Bharadwaj U, Curran MA, Diab A, Bassett RL, Tweardy DJ, Hwu P, Overwijk WW. Singh M, et al. Among authors: curran ma. Nat Commun. 2017 Nov 13;8(1):1447. doi: 10.1038/s41467-017-01572-7. Nat Commun. 2017. PMID: 29129918 Free PMC article.

5

Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.

Bartkowiak T, Singh S, Yang G, Galvan G, Haria D, Ai M, Allison JP, Sastry KJ, Curran MA. Bartkowiak T, et al. Among authors: curran ma. Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5290-9. doi: 10.1073/pnas.1514418112. Epub 2015 Sep 8. Proc Natl Acad Sci U S A. 2015. PMID: 26351680 Free PMC article.

6

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.

Ager CR, Reilley MJ, Nicholas C, Bartkowiak T, Jaiswal AR, Curran MA. Ager CR, et al. Among authors: curran ma. Cancer Immunol Res. 2017 Aug;5(8):676-684. doi: 10.1158/2326-6066.CIR-17-0049. Epub 2017 Jul 3. Cancer Immunol Res. 2017. PMID: 28674082 Free PMC article.

7

Immune checkpoint combinations from mouse to man.

Ai M, Curran MA. Ai M, et al. Among authors: curran ma. Cancer Immunol Immunother. 2015 Jul;64(7):885-92. doi: 10.1007/s00262-014-1650-8. Epub 2015 Jan 3. Cancer Immunol Immunother. 2015. PMID: 25555570 Review.

8

Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.

Jenq RR, Curran MA, Goldberg GL, Liu C, Allison JP, van den Brink MR. Jenq RR, et al. Among authors: curran ma. PLoS One. 2012;7(4):e35222. doi: 10.1371/journal.pone.0035222. Epub 2012 Apr 6. PLoS One. 2012. PMID: 22493742 Free PMC article.

9

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.

Curran MA, Kim M, Montalvo W, Al-Shamkhani A, Allison JP. Curran MA, et al. PLoS One. 2011 Apr 29;6(4):e19499. doi: 10.1371/journal.pone.0019499. PLoS One. 2011. PMID: 21559358 Free PMC article.

10

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.

Quezada SA, Peggs KS, Curran MA, Allison JP. Quezada SA, et al. Among authors: curran ma. J Clin Invest. 2006 Jul;116(7):1935-45. doi: 10.1172/JCI27745. Epub 2006 Jun 15. J Clin Invest. 2006. PMID: 16778987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results